Search

Board Moves August 27, 2018

Experienced biotech and pharmaceuticals professional, Dr Nina Webster, has been appointed chief executive and managing director of Dimerix. Dr  Webster has more than 12 years of senior executive experience, including leading investor relations and business development activities in biotech companies, in a career that spans over 25 years in the pharmaceutical and biotechnology industry. Kathy Harrison will move into the newly created role of chief operating officer.

Login

(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Dimerix (DXB)

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/09/18

1 year TSR5 year TSR
391stPointerra0%-13%
464thHazer Group-7%0%
564thDimerix-21%-5%
799thSkin Elements-71%0%
739 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

07/09/18
$5k Bought
18/07/18
$0 Bought
18/07/18
$0 Bought
Total value as at the date of the transaction
Source: Morningstar

Revenue

165th↑Pointerra$840k
166th-Skin Elements$838k
167th↓Dimerix$825k
168th↑Hazer Group$759k
169th↓Grandbridge$703k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer